The Global Saline Laxatives Market, by Age Group (Pediatric and Adult), by Route of Administration (Oral and Rectal), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 396.3 million in 2019, and is expected to exhibit a CAGR of 5.0%, during the forecast period (2019-2027).
Increasing focus of manufacturers on the development and launching of saline laxatives is expected to drive growth of the global saline laxatives market over the forecast period. For instance, in August 2017, Pendopharm, a division of Pharmascience Inc., launched Lax-A product line for the relief of occasional constipation. Moreover, rising prevalence of chronic constipation is a major factor that is expected to drive the market growth over the forecast period. For instance, according to the Abbott Gut-Health Survey, around 14% of the urban population in India suffered from chronic constipation in 2015.
Browse 36 Market Data Tables and 27 Figures spread through 135 Pages and in-depth TOC on " Global Saline Laxatives Market, by Age Group (Pediatric and Adult), by Route of Administration (Oral and Rectal), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027"
To know the latest trends and insights related to Global Saline Laxatives Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/saline-laxatives-market-2195
Moreover, manufacturers such as C.B. Fleet Company, Inc., Beutlich Pharmaceuticals, LLC, and others offers innovative oral and rectal saline laxatives. For instance, C.B. Fleet Company, Inc. offers saline enemas and oral chewable laxative tablets for adults and pediatric patients. Fleet’s saline enema comprise a gentle glide tip, and offers 25% more lubrication for ease of use and higher comfort to patients. It show the action within 1 to 5 minutes. Furthermore, saline laxatives are often used in performing colonoscopy, which is an effective screening test for colorectal cancer, wherein the patient must have an empty bowel before procedure. An alternative to colonoscopy is sigmoidoscopy, which is less invasive, however, the bowel must be fully emptied with the use of laxatives before performing sigmoidoscopy. For instance, according to the Centers for Disease Control and Prevention (CDC), the percentage of U.S. adults aged 50 to 75 years underwent colorectal cancer screening increased from 67.4% in 2016 to 68.8% in 2018 (i.e. an additional 3.5 million adults screened for colorectal cancer). Thus, increasing prevalence of colorectal cancer results in increasing preference to early screening of colon is further expected to drive growth of the market over the forecast period.
Key takeaways of the Global Saline Laxatives Market:
- The global saline laxatives market is expected to exhibit a CAGR of 5.0% during the forecast period (2019-2027), owing to innovative product offerings by major players and rising application in colonoscopy.
- Rising incidence of constipation in children is expected to increase demand for saline laxatives for pediatrics, and is expected to drive growth of the pediatric segment in saline laxatives market over the forecast period. For instance, in 2018, according to the study by researchers at University of Virginia School of Medicine, the global prevalence of rate of constipation in children ranges from 1% to 30%.
- Major players operating in the global saline laxatives market include Bayer AG, Beutlich Pharmaceuticals LLC., Prestige Consumer Healthcare Inc, Cardinal Health, Inc., Major Pharmaceuticals, Dynarex Corporation, Pharmascience Inc, and Salix Pharmaceuticals.
